Trials / Completed
CompletedNCT05842434
Pilot Study of the Felix System in Patients With Essential Tremor and Parkinson's Tremor
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Fasikl Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, open-label, multi-center pilot study designed to evaluate the safety and effectiveness of the Felix system in the relief of upper limb tremors in adults with essential tremor and Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Felix | Felix is a wrist-worn, noninvasive, transcutaneous neurostimulation system intended for daily use to suppress hand tremors. An artificial intelligence (AI) algorithm will automatically adjust the stimulation based on each patient's tremor throughout the day. |
Timeline
- Start date
- 2023-06-06
- Primary completion
- 2023-11-29
- Completion
- 2023-11-29
- First posted
- 2023-05-06
- Last updated
- 2024-06-25
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05842434. Inclusion in this directory is not an endorsement.